MoneyWorks4Me

Gland Pharma - Quaterly Results

19 May 2022 Evaluate
The Revenue for the quarter ended  March 2022 of Rs. 11030.14 millions grew by 24.25 % from Rs. 8877.48 millions.A slim rise of 9.80% was recorded in the Net profit for the quarter ended March 2022 to Rs. 2859.76  millions  From Rs. 2604.51 millions.Operating profit for the quarter ended March 2022 rose to 4136.65 millions as compared to 3749.28 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 11030.14 8877.48 24.25 44007.08 34628.76 27.08 44007.08 34628.76 27.08
Other Income 652.34 472.14 38.17 2239.40 1347.76 66.16 2239.40 1347.76 66.16
PBIDT 4136.65 3749.28 10.33 17345.79 14370.43 20.70 17345.79 14370.43 20.70
Interest 20.32 10.21 99.02 52.40 34.11 53.62 52.40 34.11 53.62
PBDT 4116.33 3739.07 10.09 17293.39 14336.32 20.63 17293.39 14336.32 20.63
Depreciation 310.75 249.22 24.69 1102.96 987.80 11.66 1102.96 987.80 11.66
PBT 3805.58 3489.85 9.05 16190.43 13348.52 21.29 16190.43 13348.52 21.29
TAX 945.82 885.34 6.83 4068.88 3378.47 20.44 4068.88 3378.47 20.44
Deferred Tax 93.23 13.13 610.05 140.08 1.20 11573.33 140.08 1.20 11573.33
PAT 2859.76 2604.51 9.80 12121.55 9970.05 21.58 12121.55 9970.05 21.58
Equity 164.30 163.59 0.43 164.30 163.59 0.43 164.30 163.59 0.43
PBIDTM(%) 37.50 42.23 -11.20 39.42 41.50 -5.02 39.42 41.50 -5.02
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..